CVS Health Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- J. David Joyner
- Full Time Employees
- 300,000
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Address
- One CVS Drive Woonsocket RI United States of America 02895
- IPO Date
- Nov 20, 1996
- CIK
- 0000064803
- Website
- cvshealth.com
- Similar Companies
- Business
- CVS Health Corporation (CVS) operates as a diversified health solutions provider, offering integrated pharmacy, health insurance, and care services across the United States through segments including Health Care Benefits via Aetna, Pharmacy Services via CVS Caremark, and retail pharmacy operations; core products and services encompass retail pharmacies with over 9,600 locations selling prescription drugs, over-the-counter medications, health and wellness products, and general merchandise; MinuteClinic walk-in clinics providing diagnostic testing, vaccinations, and primary care; pharmacy benefit management including formulary management, claims processing, mail-order and specialty pharmacy, infusion services, and long-term care pharmacy consulting; Aetna health insurance plans covering medical, pharmacy, dental, behavioral health, and Medicare options for employers, individuals, and government programs; CVS Specialty for complex chronic disease therapies; and digital tools like mobile apps for prescription management and virtual care. Founded in 1963 and headquartered in Woonsocket, Rhode Island, the company serves approximately 100 million consumers nationwide with a workforce exceeding 300,000 colleagues, focusing on underserved communities through in-home, in-store, and virtual services. Recent developments include the completion in October 2025 of its acquisition of select Rite Aid and Bartell Drugs assets, adding 63 stores in Idaho, Oregon, and Washington plus prescription files from 626 pharmacies across 15 states to expand access for over 9 million patients; an expanded partnership with a major insurer announced in November 2025 to enhance service integration; and ongoing investments in pharmacy workforce hiring and training amid strong third-quarter 2025 financial performance with raised full-year guidance.
Why CVS Health (CVS) is a Top Growth Stock for the Long-Term
Eli Lilly Wins Back CVS Health, Reverting Novo's Advantage
Here's Why CVS Health (CVS) is a Strong Value Stock
The S&P 500 Is Expensive, but These 3 Dividend Stocks Still Look Like Bargains
3 Dividend Stocks to Buy and Hold Forever
Better Dividend Growth Stock to Buy: CVS Health or UnitedHealth Group?
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
CVS Health recognized for technology that improves medication safety and patient care
Aetna launches Aetna Mental Health On Demand to provide real time access to care and ongoing support
How Safe Is CVS Health's Dividend?
Lilly's GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans
H1 Receives $40M Investment in Round Led by CVS Health Ventures
athenahealth, Aetna CVS Health, and Catalyst Health Group Recognized for Advancing Real-Time Clinical Data Exchange
CVS Health to Deliver Faster, More Personalized Call Center Care for Millions of Members with Salesforce's Agentforce Health
CVS brings back coverage for Lilly's obesity drug Zepbound
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage Options
Aetna reduces claims processing time by more than 20% with AI to improve care experience
CVS launches buyback and snaps up more vets in Australia after completing refinancing
Wall Street Week Ahead